BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11454173)

  • 41. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis.
    Tameda Y; Kosaka Y; Tagawa S; Takase K; Sawada N; Nakao H; Tsuda F; Tanaka T; Okamoto H; Miyakawa Y; Mayumi M
    J Hepatol; 1996 Dec; 25(6):842-7. PubMed ID: 9007711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma in the inshore area of the Yangtze River, China.
    Cao K; Mizokami M; Orito E; Ding X; Ueda R; Chen G; Yu SZ; Tokudome S
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1241-8. PubMed ID: 9918433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High prevalence of GB virus C strains genetically related to strains with Asian origin in Nicaraguan hemophiliacs.
    González-Pérez MA; Norder H; Bergström A; Lopéz E; Visoná KA; Magnius LO
    J Med Virol; 1997 Jun; 52(2):149-55. PubMed ID: 9179760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phylogenetic analysis of GB virus C: comparison of isolates from Africa, North America, and Taiwan.
    Kao JH; Chen PJ; Hsiang SC; Chen W; Chen DS
    J Infect Dis; 1996 Aug; 174(2):410-3. PubMed ID: 8699077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GBV-C/HGV: a new human hepatitis-related virus.
    Zanetti AR; Tanzi E; Romanò L; Galli C
    Res Virol; 1997; 148(2):119-22. PubMed ID: 9108611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular and serologic analysis in the transmission of the GB hepatitis agents.
    Schaluder GG; Dawson GJ; Simons JN; Pilot-Matias TJ; Gutierrez RA; Heynen CA; Knigge MF; Kurpiewski GS; Buijk SL; Leary TP
    J Med Virol; 1995 May; 46(1):81-90. PubMed ID: 7623012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GB virus-C/hepatitis G virus infection in Taiwan: a virus that fails to cause a disease?
    Kao J; Chen D
    J Biomed Sci; 1999; 6(4):220-5. PubMed ID: 10420079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus.
    Orii K; Tanaka E; Rokuhara A; Maruyama A; Ichijo T; Yoshizawa K; Kiyosawa K
    Intervirology; 2000; 43(3):139-45. PubMed ID: 11044807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seroepidemiology of TT virus, GBC-C/HGV, and hepatitis viruses B, C, and E among women in a rural area of Tanzania.
    Stark K; Poggensee G; Höhne M; Bienzle U; Kiwelu I; Schreier E
    J Med Virol; 2000 Dec; 62(4):524-30. PubMed ID: 11074483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Origin of GB-hepatitis viruses.
    Schlauder GG; Pilot-Matias TJ; Gabriel GS; Simons JN; Muerhoff AS; Dawson GJ; Mushahwar IK
    Lancet; 1995 Aug; 346(8972):447-8. PubMed ID: 7623597
    [No Abstract]   [Full Text] [Related]  

  • 51. The hepatitis alphabet--hepatitis A-G and TTV.
    Müller C
    Wien Klin Wochenschr; 1999 Jun; 111(12):461-8. PubMed ID: 10420504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV.
    Lau JY; Qian K; Detmer J; Collins ML; Orito E; Kolberg JA; Urdea MS; Mizokami M; Davis GL
    J Infect Dis; 1997 Aug; 176(2):421-6. PubMed ID: 9237707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular diagnostic techniques for viral hepatitis.
    Hu KQ; Vierling JM
    Gastroenterol Clin North Am; 1994 Sep; 23(3):479-98. PubMed ID: 7989090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The hepatitis G virus].
    Burkov AN; Maianskiĭ AN; Astaf'ev DG
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):94-7. PubMed ID: 9245148
    [No Abstract]   [Full Text] [Related]  

  • 55. [Viral hepatitis through time].
    Aguirre García J
    Rev Gastroenterol Mex; 1995; 60(4 Suppl 2):S12-7. PubMed ID: 8948766
    [No Abstract]   [Full Text] [Related]  

  • 56. Molecular epidemiology of GB virus C/hepatitis G virus in Athens, Greece.
    Anastassopoulou CG; Paraskevis D; Tassopoulos NC; Boletis J; Sypsa VA; Hess G; Hatzakis A
    J Med Virol; 2000 Jul; 61(3):319-26. PubMed ID: 10861639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunity against the GBV-B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long-lived.
    Bukh J; Engle RE; Govindarajan S; Purcell RH
    J Med Virol; 2008 Jan; 80(1):87-94. PubMed ID: 18041000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Primate models of human viral hepatitis].
    Poleshchuk VF; Mikhaĭlov MI; Zamiatina NA
    Vopr Virusol; 2006; 51(4):6-13. PubMed ID: 16929591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [GBV-C agent/hepatitis G virus: a new hepatitis virus?].
    Echevarría JM; León P
    Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):177-9. PubMed ID: 9312274
    [No Abstract]   [Full Text] [Related]  

  • 60. The newly discovered non A-E hepatitis viruses.
    Songsivilai S; Dharakul T
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):75-9. PubMed ID: 9031405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.